News

Suzanne McGurn, President and CEO of CADTH, is pleased to announce the appointment of new members of the CADTH Canadian Drug Expert Committee (CDEC) and the CADTH pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC), as well as a new chair and new members of the Health…

CADTH is pleased to announce the appointment of 5 new members to the CADTH Board of Directors. “I am pleased to welcome Hamida Bhimani, Avram Denburg, Chad Mitchell, Mark Wies, and Eric Bélair to the Board of Directors and look forward to the insight and leadership they will bring to CADTH,” said…

A statement from Suzanne McGurn, President and CEO, CADTH On behalf of CADTH and our Board of Directors, I’m pleased to share CADTH’s Annual Report for 2020–2021, my first as President and CEO. Read the Report The theme of this year’s report — “unprecedented,” — is in recognition of a year like…

In our new podcast episode, Suzanne McGurn, President and CEO of CADTH, is in conversation with Dr. Wendy Levinson, Chair of Choosing Wisely Canada — the national voice for reducing unnecessary tests and treatments in health care. Suzanne and Dr. Levinson discuss the role of Choosing Wisely Canada…

September 17, 2021 CADTH has launched a survey to explore which new or emerging health technologies or trends could impact Canada’s health care system over the next 2 to 3 years. The results of the survey will create awareness of potentially important and transformative health technologies and…